XML 127 R68.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Information - Combined income statements (Details) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Disclosure of operating segments [line items]      
Net sales to third parties $ 6,763,000,000 $ 7,362,000,000 $ 7,149,000,000
Sales to former parent   0 4,000,000
Other revenues 70,000,000 146,000,000 0
Net sales and other revenues 6,833,000,000 7,508,000,000 7,153,000,000
Segment contribution 1,091,000,000 1,537,000,000 1,446,000,000
Amortization of intangible assets (1,078,000,000) (1,084,000,000) (1,019,000,000)
Impairment charges on intangible assets (167,000,000) 0 (378,000,000)
General & administration (corporate) (232,000,000) (216,000,000) (206,000,000)
Separation costs (217,000,000) (237,000,000) 0
Spin readiness costs 0 (72,000,000) (32,000,000)
Transformation costs (49,000,000) (52,000,000) 0
Payables contingent consideration (63,000,000) (75,000,000) (62,000,000)
Past service costs for post-employment benefit plan amendments 154,000,000 (2,000,000) (1,000,000)
Other (47,000,000) (136,000,000) (120,000,000)
Operating (loss) (482,000,000) (187,000,000) (248,000,000)
Interest expense (124,000,000) (113,000,000) (24,000,000)
Other financial income & expense (29,000,000) (32,000,000) (28,000,000)
(Loss) before taxes (635,000,000) (332,000,000) (300,000,000)
Depreciation of property, plant & equipment (293,000,000) (267,000,000) (239,000,000)
Depreciation of right-of-use assets (79,000,000) (66,000,000) 0
Impairment charges on property, plant & equipment, net (6,000,000) (8,000,000) (2,000,000)
Equity-based compensation (113,000,000) (114,000,000) (93,000,000)
Contingent Consideration Asset (Liability), Fair Value Adjustment 63,000,000 75,000,000 62,000,000
Unallocated amounts [member]      
Disclosure of operating segments [line items]      
Depreciation of property, plant & equipment 0 0 0
Depreciation of right-of-use assets 0 0 0
Impairment charges on property, plant & equipment, net 0 0 0
Equity-based compensation (13,000,000) (15,000,000) (12,000,000)
Surgical [member]      
Disclosure of operating segments [line items]      
Net sales to third parties 3,710,000,000 4,174,000,000 3,999,000,000
Sales to former parent   0 2,000,000
Other revenues 0 0 0
Net sales and other revenues 3,710,000,000 4,174,000,000 4,001,000,000
Segment contribution 672,000,000 957,000,000 846,000,000
Impairment charges on intangible assets (66,000,000) 0 (378,000,000)
Surgical [member] | Operating segments [member]      
Disclosure of operating segments [line items]      
Depreciation of property, plant & equipment (122,000,000) (112,000,000) (114,000,000)
Depreciation of right-of-use assets (47,000,000) (42,000,000) 0
Impairment charges on property, plant & equipment, net (6,000,000) (3,000,000) (1,000,000)
Equity-based compensation (55,000,000) (55,000,000) (45,000,000)
Vision Care [member]      
Disclosure of operating segments [line items]      
Net sales to third parties 3,053,000,000 3,188,000,000 3,150,000,000
Sales to former parent   0 2,000,000
Other revenues 70,000,000 146,000,000 0
Net sales and other revenues 3,123,000,000 3,334,000,000 3,152,000,000
Segment contribution 419,000,000 580,000,000 600,000,000
Impairment charges on intangible assets (101,000,000) 0 0
Vision Care [member] | Operating segments [member]      
Disclosure of operating segments [line items]      
Depreciation of property, plant & equipment (171,000,000) (155,000,000) (125,000,000)
Depreciation of right-of-use assets (32,000,000) (24,000,000) 0
Impairment charges on property, plant & equipment, net 0 (5,000,000) (1,000,000)
Equity-based compensation $ (45,000,000) $ (44,000,000) $ (36,000,000)